Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
What explains functioning from the perspective of people with multiple sclerosis?
MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas.
Acute Disseminated Encephalomyelitis Following 2009 H1N1 Influenza Vaccination.
Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits.
Oligodendrocyte Precursor Cell-Intrinsic Effect of Rheb1 Controls Differentiation and Mediates mTORC1-Dependent Myelination in Brain.
Triptolide with Potential Medicinal Value for Diseases of the Central Nervous System.
Advanced MRI in multiple sclerosis: current status and future challenges.
Assessment and rehabilitation of driver skills: subjective experiences of people with multiple sclerosis and health professionals.
Adverse socioeconomic position during the life course is associated with multiple sclerosis.
Comparison of brain 3.0-T with 1.5-T MRI in patients with multiple sclerosis: A 6-month follow-up study.
What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?
Fingolimod affects gene expression profile associated with LPS-induced memory impairment.
Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.
The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.
The meninges: new therapeutic targets for multiple sclerosis.
[Translation and cross-cultural adaptation of the Multiple Sclerosis Walking Scale (MSWS-12) into Brazilian Portuguese].
Antibodies to potassium channels in multiple sclerosis.
[Neuromyelitis optica in children. Two case reports.]
Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients.
[Amino acids content in the blood serum of patients with multiple sclerosis.]
Smokers run increased risk of developing anti-natalizumab antibodies.
Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
Moral Distress: Recognition, Diagnosis, and Treatment.
Explaining temporal trends in annualised relapse rates in placebo groups of randomised controlled trials in relapsing multiple sclerosis: systematic review and meta-regression.
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
Pages
« first
‹ previous
…
282
283
284
285
286
287
288
289
290
…
next ›
last »